Mediste Pharmaceutical Private Limited, a active private limited company, was established on 30 June 2017 in New Delhi, Delhi, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U74999DL2017PTC320020. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.75 M.
It upholds a compliant status. Its leadership includes Shitiz Sukhija (Director), Rohit Diwan (Director), Prem Madan (Director). Past directors included Shitiz Sukhija. It holds ₹4.42 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot-1 Kh No-309 G/F,, Shivpuri Deenpur Extn Najafgarh, New Delhi, Delhi, 110043.
U74999DL2017PTC320020
320020
30 June 2017
₹1.00 M
₹0.75 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Mediste Pharmaceutical Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shitiz Sukhija | Director | 09 Jul 2018 | Current |
| Rohit Diwan | Director | 30 Jun 2017 | Current |
| Prem Madan | Director | 30 Jun 2017 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 29 Sep 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Mediste Pharmaceutical Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 96.1% increase. The company also saw a substantial improvement in profitability, with a 97.61% increase in profit. The company's net worth Soared by an impressive increase of 74.08%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Mediste Pharmaceutical had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹44,205,761.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Jan 2024 | Others | ₹4.30 Cr | Open |
| 19 Nov 2020 | Hdfc Bank Limited | ₹1.21 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Mediste Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Mediste Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mediste Pharmaceutical's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Mediste Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
The activity Mediste Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was completed.
A charge with Others amounted to Rs. 43.00 M with Charge ID 100867467 was registered on 10 Jan 2024. was recorded as a recent event.
A charge with Hdfc Bank Limited amounted to Rs. 1.21 M with Charge ID 100394056 was registered on 19 Nov 2020. was recorded as a recent event.
Shitiz Sukhija was appointed as a Director was appointed as a Director on 09 Jul 2018 & has been associated with this company since 7 years 4 months . was recorded as a recent event.
Progress on Rohit Diwan was appointed as a Director was appointed as a Director on 30 Jun 2017 & has been associated with this company since 8 years 4 months . was documented.
The CIN of Mediste Pharmaceutical Private Limited is U74999DL2017PTC320020.
Mediste Pharmaceutical Private Limited is headquartered at Plot-1 Kh No-309 G/F,, Shivpuri Deenpur Extn Najafgarh, New Delhi, Delhi, 110043.
Mediste Pharmaceutical Private Limited was incorporated on 30 June 2017.
The current directors of Mediste Pharmaceutical Private Limited are
The primary industry of Mediste Pharmaceutical Private Limited is Trade.
Mediste Pharmaceutical Private Limited is unlisted.
The authorized capital of Mediste Pharmaceutical Private Limited is ₹1.00 M, and the paid-up capital is ₹0.75 M.
The compliance status of Mediste Pharmaceutical Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX